IBD-RESPONSE will work with another study already underway in the UK. The IBD BioResource is a large study of over 35,000 patients, currently recruiting people with Crohn’s and colitis from hospitals across the UK.
The main aim of the IBD BioResource is to understand how human genes may cause or protect from Crohn’s and colitis, and to link patients to research in order to help understand what drives these conditions and develop new and better treatments.
IBD-RESPONSE will work closely with the IBD BioResource and if you are not already part of the IBD BioResource, you will be asked if you would like to take part in the IBD BioResource within 12 months of consenting to this study, and you will be contacted by a member of your local research team or the IBD BioResource team and be provided with further information. By being part of the IBD BioResource the information collected in IBD-RESPONSE can help both studies and be used to support more research in the future.
